Texas Oncology-Plano East

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer3 trials
• Gastric and oesophageal cancer2 trials
• Lung cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 34 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Eli Lilly and Company1 trial
• Gilead Sciences1 trial
• Hoffmann-La Roche1 trial
• Stemline Therapeutics, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

  NCT06038578· Phase 2· Toray Industries, Inc· Source

  Contact: Pre-Screener

• Active, not recruiting

  Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

  NCT05169567· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· Phase 3· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and oesophageal cancer1 recruiting

Closed trials

• Completed

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· Phase 3· Stemline Therapeutics, Inc.· Source

• Recruiting

  A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

  NCT03424005· Phase 1/2· Hoffmann-La Roche· Source

• Completed

  Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

  NCT02872116· Phase 3· Bristol-Myers Squibb· Source